-
*Kazuma HIGASHISAKA
Laboratory of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University Laboratory of Biopharmaceutical Research, National Institute of Biomedical Innovation
-
Akiyoshi KUNIEDA
Laboratory of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University
-
Yohei MUKAI
Laboratory of Biopharmaceutical Research, National Institute of Biomedical Innovation
-
Haruhiko KAMADA
Laboratory of Biopharmaceutical Research, National Institute of Biomedical Innovation
-
Kazuya NAGANO
Laboratory of Biopharmaceutical Research, National Institute of Biomedical Innovation
-
Yuki IWAHARA
Laboratory of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University
-
Kota TANAKA
Laboratory of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University
-
Hideki MOCHIZUKI
Osaka University Graduate School of Medicine
-
Shin-ichi TSUNODA
Laboratory of Biopharmaceutical Research, National Institute of Biomedical Innovation MEI center, Osaka University
-
Yasuo YOSHIOKA
Laboratory of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University Laboratory of Biopharmaceutical Research, National Institute of Biomedical Innovation
-
Yasuo TSUTSUMI
Laboratory of Toxicology and Safety Science, Graduate School of Pharmaceutical Sciences, Osaka University MEI center, Osaka University